These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30244692)

  • 21. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
    Ardley HC; Hung CC; Robinson PA
    FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for the identification of ubiquitin ligase inhibitors.
    Goldenberg SJ; Marblestone JG; Mattern MR; Nicholson B
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):132-6. PubMed ID: 20074047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. We Are What We Eat: Ubiquitin-Proteasome System (UPS) Modulation Through Dietary Products.
    Panagiotidou E; Chondrogianni N
    Adv Exp Med Biol; 2020; 1233():329-348. PubMed ID: 32274765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disordered Substrates of the 20S Proteasome Link Degradation with Phase Separation.
    Guharoy M; Lazar T; Tompa P
    Proteomics; 2018 Nov; 18(21-22):e1800276. PubMed ID: 30070766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.
    Tundo GR; Sbardella D; Santoro AM; Coletta A; Oddone F; Grasso G; Milardi D; Lacal PM; Marini S; Purrello R; Graziani G; Coletta M
    Pharmacol Ther; 2020 Sep; 213():107579. PubMed ID: 32442437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PA28γ: New Insights on an Ancient Proteasome Activator.
    Cascio P
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in Proteasome Enhancement by Small Molecules.
    George DE; Tepe JJ
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescent reporters for the ubiquitin-proteasome system.
    Salomons FA; Verhoef LG; Dantuma NP
    Essays Biochem; 2005; 41():113-28. PubMed ID: 16250901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ionizing radiation exposure on Trypanosoma cruzi ubiquitin-proteasome system.
    Cerqueira PG; Passos-Silva DG; Vieira-da-Rocha JP; Mendes IC; de Oliveira KA; Oliveira CF; Vilela LF; Nagem RA; Cardoso J; Nardelli SC; Krieger MA; Franco GR; Macedo AM; Pena SD; Schenkman S; Gomes DA; Guerra-Sá R; Machado CR
    Mol Biochem Parasitol; 2017 Mar; 212():55-67. PubMed ID: 28137628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.
    Njomen E; Tepe JJ
    J Med Chem; 2019 Jul; 62(14):6469-6481. PubMed ID: 30839208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardium.
    Wohlschlaeger J; Sixt SU; Stoeppler T; Schmitz KJ; Levkau B; Tsagakis K; Vahlhaus C; Schmid C; Peters J; Schmid KW; Milting H; Baba HA
    J Heart Lung Transplant; 2010 Jan; 29(1):125-32. PubMed ID: 19837610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts.
    Liu J; Chen Q; Huang W; Horak KM; Zheng H; Mestril R; Wang X
    FASEB J; 2006 Feb; 20(2):362-4. PubMed ID: 16371426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 20S proteasome activation promotes life span extension and resistance to proteotoxicity in Caenorhabditis elegans.
    Chondrogianni N; Georgila K; Kourtis N; Tavernarakis N; Gonos ES
    FASEB J; 2015 Feb; 29(2):611-22. PubMed ID: 25395451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
    Dennissen FJ; Kholod N; van Leeuwen FW
    Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of b-AP15 on the 20S proteasome.
    Huang L; Jung K; Chen CH
    Biomolecules; 2014 Oct; 4(4):931-9. PubMed ID: 25317846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Disordered Landscape of the 20S Proteasome Substrates Reveals Tight Association with Phase Separated Granules.
    Myers N; Olender T; Savidor A; Levin Y; Reuven N; Shaul Y
    Proteomics; 2018 Nov; 18(21-22):e1800076. PubMed ID: 30039638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of proteasomes in prion disease.
    Zhu T; Hayat Khan S; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):531-9. PubMed ID: 24829398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ubiquitin proteasome system in neuropathology.
    Lehman NL
    Acta Neuropathol; 2009 Sep; 118(3):329-47. PubMed ID: 19597829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
    Lin Z; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.